Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30088483HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS30063793HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS30063794HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20008491HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20043606HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20023643HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TCGA Plot Options
Drug Information
GeneHTR4
DrugBank IDDB01079
Drug NameTegaserod
Target IDBE0000084
UniProt IDQ13639
Regulation Typeantagonist
PubMed IDs11207504; 11876686; 12150698; 15466450; 15645012; 11752352
CitationsCamilleri M: Review article: tegaserod. Aliment Pharmacol Ther. 2001 Mar;15(3):277-89.@@Kamm MA: Review article: the complexity of drug development for irritable bowel syndrome. Aliment Pharmacol Ther. 2002 Mar;16(3):343-51.@@Corsetti M, Tack J: Tegaserod: a new 5-HT(4) agonist in the treatment of irritable bowel syndrome. Expert Opin Pharmacother. 2002 Aug;3(8):1211-8.@@Beattie DT, Smith JA, Marquess D, Vickery RG, Armstrong SR, Pulido-Rios T, McCullough JL, Sandlund C, Richardson C, Mai N, Humphrey PP: The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol. 2004 Nov;143(5):549-60. Epub 2004 Oct 4.@@Cole P, Rabasseda X: Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndrome. Drugs Today (Barc). 2004 Dec;40(12):1013-30.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved; Investigational; Withdrawn
Direct ClassificationIndoles
SMILESCCCCCNC(=N)NN=CC1=CNC2=C1C=C(OC)C=C2
Pathways
PharmGKBPA130413154
ChEMBLCHEMBL76370